WATERTOWN, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals, a therapeutics company focused on discovering and developing novel gene control therapies, will present a corporate overview at the 2015 Leerink Global Healthcare Conference, which takes place February 11 to 12, 2015, at the Waldorf Astoria Hotel in New York, New York. Syros CEO Nancy Simonian, MD, will present on Thursday, February 12, 2015, from 11:10 to 11:30 a.m. Eastern Time.
About Syros Pharmaceuticals
Syros Pharmaceuticals is a therapeutics company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases. Syros’ proprietary platform identifies the master switches for disease genes, opening a whole new approach to novel therapeutics and biomarkers. The company’s founders are pioneers in gene control research and translation. Co-founded by Flagship Ventures and ARCH Venture Partners, Syros Pharmaceuticals is located in Watertown, MA. For more information, visit www.syros.com.
Sam Brown Inc.
Mariesa Kemble, 608-850-4745
mariesakemble@sambrown.com
Source: Syros Pharmaceuticals
Released February 9, 2015